 Faropenem is an oral penem, closely related to the carbapenem class that is used for the treatment of bacterial infections. It has in vitro activity against Mycobacterium tuberculosis and this trial aims to determine the activity of faropenem with amoxicillinclavulanic acid in patients with pulmonary TB. 